AzTrials
AzTrials

Health BehaviorsNCT04912739

Targeted Health Dialogues in Primary Care

An observational study of Health Behaviors and Risk Factors, run by Region Skane at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The County Council of Region Skåne, Sweden, has recently initiated Targeted Health Dialogues in primary care. The prevention program includes health dialogues provided by specially trained personnel, collection of clinical and laboratory data as well as questionnaire data on, e.g., individual health and health… Read more about this study

Who is it for?
Ages 40 to 70 years
What is being tested?
Targeted health dialogues
How many people
18,000 participants
Where
1 siteSweden
Study dates
1 Oct 2020to 31 Dec 2040
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • Adult, Older adult

Study population: In Sweden, most people are listed at one healthcare center. The study population consists of all listed 40-, 50-, 60-year, and 70-year-old patients that perform a targeted health dialogue and consent to take part in the research study.

Who may be able to join

  • 40-, 50-, 60-, and 70-year old men and women
  • Listed at a healthcare center in Skåne county

Who cannot join

  • Inability to understand the written study information and give informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristina Sundquist, PhD, MD contact

+46 (0)40 391 376

kristina.sundquist@med.lu.se

Hanna Glock, MD, PhD contact

hanna.glock@med.lu.se

Sweden1 site, 1 recruiting
  • Center for Primary Health Care Research, Lund University and Region Skåne

    Malmö, Skåne County, 20502

    Kristina Sundquist, PhD, MD, +46 (0)40 391 376, kristina.sundquist@med.lu.se

    Hanna Glock, PhD, MD, hanna.glock@med.lu.se

    Recruiting

Other trials in Sweden

About this study

Official title: Targeted Health Dialogues in Primary Care: Lifestyle Screening and Molecular Profiling for a Healthier Life

The County Council of Region Skåne, Sweden, has recently initiated Targeted Health Dialogues in primary care. The prevention program includes health dialogues provided by specially trained personnel, collection of clinical and laboratory data as well as questionnaire data on, e.g., individual health and health behaviors. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. A research project will be integrated within the program where the collected data will be linked, on the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. Blood samples will be collected for analyses of molecular biomarkers. The research project will examine associations between potential predictors and future risk of cardiovascular diseases and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined, and whether the protocol needs to be modified in order to develop more precise and personalized medicine.

Read the detailed description

The County Council of Region Skåne, the third most populous region in Sweden with 1.4 million inhabitants, has recently initiated Targeted Health Dialogues in primary care with the ultimate goal to improve cardiovascular health in the entire population in Skåne. Targeted health dialogues have previously been proven to improve health behaviors and risk factors and decrease the incidence of cardiovascular disease and mortality. The prevention program includes, in addition to the health dialogues provided by specially trained personnel, collection of clinical and laboratory data (e.g. blood pressure, BMI, waist hip ratio, lipids, fasting blood glucose) as well as detailed questionnaire data on, e.g., individual health and symptoms, family history, diet, physical activity, alcohol and smoking. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. The County Council and the Ethical Review Board have granted permission to integrate a research project within the program where collected data will be linked, at the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. In addition to the collection and linkages of these data, blood samples will be collected for analyses of molecular biomarkers. The research project will allow for examining associations between a number of potential predictors and future risk of cardiovascular disease and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined and whether the protocol needs to be modified in order to develop more precise and personalized medicine.

Being tested
Targeted health dialogues
Medical subject headings
Health Behavior, Cardiovascular Diseases, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Targeted health dialoguesBehavioural

    Before the targeted health dialogue, the participants fill in a questionnaire about health behaviors, background characteristics and self-rated health. Samples for blood glucose and total cholesterol are taken. BMI, waist-to-hip ratio and blood pressure are measured. The results are summoned in a "health curve", which is discussed with specially trained healthcare personnel in a Targeted heath dialogue. In a sub-group, blood samples are collected for molecular analyses.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of targeted health dialogues on CVD incidence

    The short- and long-term effect of targeted health dialogues on incidence of CVD events, its comorbidity and CVD-related deaths in the participants compared to a general population cohort and historical controls.

    Measured: 2035

  2. Effect of targeted health dialogues on incidence of cancer and other serious diseases

    The short- and long-term effect of targeted health dialogues on incidence of cancer and other serious diseases in the participants compared to a general population cohort and historical controls.

    Measured: 2035

Secondary outcomes (14)
  1. Modification by individual characteristics

    Modification of possible associations between targeted health dialogues and future CVD, cancer, other serious diseases and preterm death by individual characteristics (e.g., sociodemographic factors)

    Measured: 2035

  2. Association between risk factors and disease incidence

    Associations between risk factors/combination of risk factors (lifestyle-related, metabolic, psychosocial and familial) at baseline and incidence of CVD, cancer, other serious diseases and preterm death.

    Measured: 2035

  3. Identification of molecular biomarkers

    The ability of biological aging, epigenetic changes and genetic and metabolomic profiles to predict CVD, cancer, other serious diseases and preterm death as well as the effect of targeted health dialogues.

    Measured: 2035

  4. Public health profile of middle-aged citizens in Sweden's southernmost county

    Level of physical activity and sedentary behavior, intake of healthy/unhealthy food, alcohol consumption, smoking habits, stress, psychological well-being, blood glucose, cholesterol, BMI, waist-hip ratio. Comparisons between subgroups: age, sex, sociodemography, previous diagnoses.

    Measured: 2035

  5. Associations between dental and general health

    Associations between dental health at baseline and incidence of CVD, cancer, other serious diseases and preterm death.

    Measured: 2035

  6. Validation of the targeted health dialogue method

    Validity and reliability of the questionnaire and targeted health dialogue method

    Measured: 2035

  7. Health economy

    Costs related to the targeted health dialogues versus individual and societal gains.

    Measured: 2035

  8. The effect of targeted health dialogues on health behaviors and self-rated health

    Measured: 2035

  9. Do targeted health dialogues reach all societal groups?

    Measured: 2035

  10. Can other lifestyle interventions influence the effect of targeted health dialogues?

    Measured: 2035

  11. Follow-up of samples taken after the targeted health dialogues.

    Which samples and tests were taken as a result of the targeted health dialogues?

    Measured: 2035

  12. Do the the targeted health dialogues influence care seeking?

    Evaluation of new search patterns due to the targeted health dialogues.

    Measured: 2035

  13. Obstacles and motivators for physical activity

    What obstacles and motivators for physical activity do inactive people experience?

    Measured: 2035

  14. Effect of targeted health dialogues on blood metabolites

    Do targeted health dialogues affect food-related metabolites in the blood?

    Measured: 2035

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2021
  2. Study start1 Oct 2020
  3. Primary completion31 Dec 2030 (estimated)
  4. Study completion31 Dec 2040 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
18,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04912739
Sponsor's protocol ID
2020-02689
Status last verified
Oct 2026
First submitted
23 Apr 2021
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Nymberg P, Milos-Nymberg V, Grundberg A, Oscarson N, Stenman E, Sundquist K. Exploring the link between self-rated poor oral health and cardiovascular risk: a cross-sectional study using SCORE2. BMC Oral Health. 2025 Feb 24;25(1):298. doi: 10.1186/s12903-025-05671-6.

    PubMed 39994610
  • Stenman E, Borgstrom Bolmsjo B, Grundberg A, Sundquist K. Health determinants among participants in targeted health dialogues offered to all 40-year-old individuals in a metropolitan region of 1.4 million people. Scand J Prim Health Care. 2025 Mar;43(1):24-35. doi: 10.1080/02813432.2024.2385547. Epub 2024 Aug 1.

    PubMed 39091122

Questions about this trial

What is this clinical trial studying?

An observational study of Health Behaviors and Risk Factors, run by Region Skane at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kristina Sundquist, PhD, MD (+46 (0)40 391 376, kristina.sundquist@med.lu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of targeted health dialogues on CVD incidence (time frame: 2035). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04912739, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in